TXNDC11 and renal cell carcinoma: Furthermore, they proposed circ-TXNDC11 as a potential therapeutic agent for RCC treatment, since circ-TXNDC11 silencing causes cell proliferation and invasion suppression in vitro, and reduced tumor growth in a mice model (Yang et al., 2021).